Our overall objectives are to 1) follow-up the second and third generation cohorts at Dartmouth, 2) lead the five-center third generation study, and 3) lead and contribute to manuscript development. Follow-up activities include tracing cohort members, sending questionnaires, conducting telephone interviews, obtaining written consent for medical record access, retrieving medical records, and submitting data to the coordinating center. We will also lead the third generation study. Broadly, this responsibility includes maintaining the third generation cohort registry, overseeing data collection, and documenting operational decisions. We will develop third generation study-related materials, including the study protocol, questionnaire, pathology abstraction forms, and transmittal forms. Incoming data will be entered into electronic files, double-entered, and verified. Questionnaires and non response forms will be reconciled with other data sources, including the cohort registry and the study centers' progress reports. The computerized data will be edited and cleaned, and analyses files will be created and distributed to other centers. We also propose to continue our role in manuscript development. Currently, the Dartmouth study center leads three papers, covering three generations of the cohorts, and additional papers will be undertaken when the follow-up data are mature. We will also continue to contribute to manuscripts initiated at the other study centers.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
No Project Terms available.
Details
Other PIs
Not Applicable
Program Official
Name
Contact
Email not available
Organization
Name
City
Country
UNITED STATES
Department Type
Unavailable
Organization Type
Unavailable
State Code
Congressional District
Other Information
Opportunity Number
Study Section
Fiscal Year
2007
Award Notice Date
Administering Institutes or Centers
National Cancer Institute
CFDA Code
DUNS Number
UEI
Project Start Date
30-September-2005
Project End Date
29-September-2010
Budget Start Date
Budget End Date
Project Funding Information for 2007
Total Funding
$263,182
Direct Costs
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2007
National Cancer Institute
$263,182
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for N01CP55511-3-0-1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for N01CP55511-3-0-1
Patents
No Patents information available for N01CP55511-3-0-1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for N01CP55511-3-0-1
Clinical Studies
No Clinical Studies information available for N01CP55511-3-0-1
News and More
Related News Releases
No news release information available for N01CP55511-3-0-1
History
No Historical information available for N01CP55511-3-0-1
Similar Projects
No Similar Projects information available for N01CP55511-3-0-1